Jenscare Scientific Co (HKSE:09877) Forward Dividend Yield %: 0.00% (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09877 Jenscare Scientific Co Ltd HKSE:09877
33 GF Score
Price HK$7.49
! 4 Warning Signs
View Full Analysis

What is Jenscare Scientific Co Forward Dividend Yield %?

Jenscare Scientific Co HKSE:09877 +0.60% 33 Forward Dividend Yield % is 0.00% as of Aug. 18, 2026. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 313 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 319488.5% on this metric.

As of today (2026-08-18), the Forward Annual Dividend Yield of Jenscare Scientific Co is 0.00%.

As of today (2026-08-18), the Trailing Annual Dividend Yield of Jenscare Scientific Co is 0.00%.

HKSE:09877's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.04
* Ranked among companies with meaningful Forward Dividend Yield % only.

Jenscare Scientific Co's Dividends per Share for the six months ended in Dec. 2025 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Jenscare Scientific Co  (HKSE:09877) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Jenscare Scientific Co Forward Dividend Yield % Related Terms


HKSE:09877 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Jenscare Scientific Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jenscare Scientific Co Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Jenscare Scientific Co's Forward Dividend Yield % falls into.


HKSE:09877
33GF Score
Jenscare Scientific Co Ltd HKSE:09877
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jenscare Scientific Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Jenscare Scientific Co (HKSE:09877) has a Forward Dividend Yield % of 0.00% as of Aug. 18, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Jenscare Scientific Co and its competitors. According to the industry distribution chart, Jenscare Scientific Co ranks #999999 out of 313 companies in the Medical Devices & Instruments industry.
Is Jenscare Scientific Co's Forward Dividend Yield % too high?
Jenscare Scientific Co's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Jenscare Scientific Co ranks #999999 out of 313 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #999999 out of 313 companies for Forward Dividend Yield %. This places Jenscare Scientific Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.04, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current Forward Dividend Yield % is 0.00% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jenscare Scientific Co Business Description

Address No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score

Get the complete analysis for HKSE:09877

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.49
Price